TIP_link_300x300.jpg
Genotyping Market Size Worth $79.4Bn by 2028 at 20.1% CAGR, Colossal Market Share (by F. Hoffmann-La Roche Ltd. & Illumina, Inc.), Lead by Product and Services Segment, Deep Dive Global Analysis by The Insight Partners
June 30, 2022 09:48 ET | The Insight Partners
New York, June 30, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Genotyping Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product and Service...
InterpaceBiosciences_New Logo.png
Interpace Biosciences Announces U.S. PTO Issuance of Patent No. 11,143,657 Titled: Topographic Genotyping for Determining the Diagnosis, Malignant Potential, and Biologic Behavior of Pancreatic Cysts and Related Conditions
October 28, 2021 08:15 ET | Interpace Biosciences, Inc.
PARSIPPANY, NJ, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG), a fully integrated commercial company that provides clinically relevant...
22157.jpg
Global Genome Sequencing Market Report 2021-2026 Featuring Prominent Players - Illumina, Thermo Fisher Scientific, Oxford Nanopore Technology, Pacific Biosciences, F. Hoffmann-La Roche, & BGI
March 29, 2021 05:23 ET | Research and Markets
Dublin, March 29, 2021 (GLOBE NEWSWIRE) -- The "Genome Sequencing Market - Global Outlook and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global genome...
22157.jpg
Outlook on the Pharmacogenomics Global Market to 2030 - Trend Forecasts and Growth Opportunities
February 10, 2021 07:33 ET | Research and Markets
Dublin, Feb. 10, 2021 (GLOBE NEWSWIRE) -- The "Global Pharmacogenomics Market 2020-2030 by Service (Genotyping, SNP, Diagnostics), Technology (PCR, Microarray, Sequencing, Electrophoresis, MS),...
NLA LOGO - USE.png
National Lipid Association Releases Official Scientific Statement on Genetic Testing in Dyslipidemia
July 10, 2020 12:30 ET | National Lipid Association
JACKSONVILLE, Fla., July 10, 2020 (GLOBE NEWSWIRE) -- The National Lipid Association (NLA) today announced the release of its official scientific statement on the use of genetic testing in the...
Logo.png
Interpace to Present at the 21st Annual Global Investment Conference Sponsored by H.C. Wainwright
September 06, 2019 06:55 ET | Interpace Diagnostics Group, Inc.
PARSIPPANY, NJ, Sept. 06, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (“Interpace” or the “Company”) (NASDAQ: IDXG) today announced that the Company will present at the upcoming 21st...
ARUP Laboratories an
ARUP Laboratories and The Children's Hospital of Philadelphia Form Partnership to Offer High-resolution HLA genotyping by Next Generation Sequencing
October 08, 2014 11:11 ET | ARUP Laboratories
SALT LAKE CITY, Oct. 8, 2014 (GLOBE NEWSWIRE) -- ARUP Laboratories announced today that they will be offering high-resolution HLA genotyping by next generation sequencing (NGS) under an agreement with...